2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Adverse Event: new trials by email Literature Review of Adverse Event trials Research Report on Adverse Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Versus Conventional Cessation of Hydrocortisone in Septic Shock normal saline solution, Hydrocortisone and normal saline solution - Septic Shock, Adverse Event | Phase 2 | Unknown | Mahidol University | 160 | 2023-07-05 | 2024-04-05 |
| Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Akynzeo, Dexamethasone - Chemotherapy-induced Nausea and Vomiting, Adverse Event | Phase 2 / Phase 3 | Unknown | Christina Ruhlmann | 80 | 2018-09-05 | 2021-12-14 |
Hyperglycemia (1) · Hypernatremia (1) · Muscle Weakness (1) · Shock, Septic (1) · Superinfection (1) · Uterine Cervical Neoplasms (1) · Vomiting (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Glucose Metabolism Disorders (1) · Infections (1) · Inflammation (1) · Metabolic Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
Dexamethasone (1) · Hydrocortisone (1) · Saline Solution (1) · netupitant, palosentron drug combination (1)
Christina Ruhlmann (1) · Mahidol University (1)
Denmark (1) · Thailand (1)
Christina H. Ruhlmann, MD, PhD (1) · Surat Tongyoo, Doctor (1)